Mr Jose Trevejo

Chief Medical Officer at Enveda Biosciences

Speaker

José Trevejo MD, PhD is a physician-scientist and biotechnology executive who has led organizations in the development of high impact medicines spanning multiple therapeutic areas. Currently he is the Chief Medical Officer and Head of Clinical Pipeline Strategy at Enveda Biosciences which is developing new medicines from natural products utilizing AI. Prior to Enveda he was the CMO of Tarsus Pharma where he helped lead the FDA approval and successful launch of a novel category-creating ophthalmology drug. Dr. Trevejo also served as CDO for Rocket Pharmaceuticals and CEO of the non-viral gene therapy company SmartPharm, which was acquired in 2020. Prior to SmartPharm, Jose held increasing roles of responsibility at Ironwood, Genentech and Vertex Pharmaceuticals. Jose Trevejo received his M.D. and Ph.D. at the Cornell-Rockefeller-Sloan Kettering Tri-Institutional M.D./Ph.D. Program and completed his residency and specialty training at Harvard Medical School affiliates BWH and BIDMC.